Tablet Ginger Versus Tablet Doxylamine Succinate in Control of Nausea and Vomiting in Pregnancy

Launched by NAWAZ SHARIF MEDICAL COLLEGE · Jan 9, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of two treatments for nausea and vomiting during pregnancy, a common issue known as nausea gravidarum or hyperemesis gravidarum. The trial will compare the use of ginger tablets, a natural remedy, with Doxylamine succinate, a standard medication used to treat these symptoms. The goal is to see which treatment better helps reduce nausea and vomiting in pregnant women.

To participate, women must be over 18 years old, between 5 to 11 weeks pregnant, and experiencing nausea and vomiting. They should also be attending the outpatient department and have a confirmed pregnancy through an ultrasound. Participants will receive either ginger or Doxylamine for one week, and their symptoms will be assessed before and after treatment to see how much they improve. It's important to note that women with certain medical conditions or who are hospitalized for severe nausea will not be eligible for this trial. If you're considering joining, you'll need to provide consent to participate.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women age\>18 years
• • 5 to 8weeks of gestation and 8+1to11weeks
• • Attending OPD with signs and symptoms of nausea and vomiting with ultrasound confirmed pregnancy
• • 1st and 2nd gravida
• • Patients who will give consent
• Exclusion Criteria:
• • Patients were hospitalized for Hyperemesis Gravidarum
• • Medical disorders like Diabetes Mellitus, Hepatic, Gastric, Pancreatic, Pyelonephritis, Thyroid and Psychological Disorder
• • Patients not responding to treatment after 1week will be excluded
• • Patients who will not give consent